Profil
Dominique G.
Petitgenet worked as Principal at Rhodia, Inc., Montedison Usa, Inc., and Rhone-Poulenc Pharmaceuticals, Inc. From 2005 to 2012, worked at Merial, Inc., serving as Chief Financial Officer in 2012.
From 2012 to 2023, worked at Immucor, Inc. as Chief Financial Officer & Executive Vice President.
Education includes graduate degree from Université Paris Dauphine-PSL.
Anciens postes connus de Dominique G. Petitgenet
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUCOR, INC. | Directeur Financier/CFO | 01/03/2023 |
Merial, Inc.
Merial, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products and vaccines for pets, production animals, horses, and wildlife | Directeur Financier/CFO | 01/01/2012 |
Montedison Usa, Inc. | Corporate Officer/Principal | - |
Rhodia, Inc.
Rhodia, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and engineering plastics | Corporate Officer/Principal | - |
Rhone-Poulenc Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formation de Dominique G. Petitgenet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Immucor, Inc.
Immucor, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells transfusion and transplantation diagnostics products | Health Technology |
Rhodia, Inc.
Rhodia, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and engineering plastics | Process Industries |
Université Paris Dauphine-PSL
Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merial, Inc.
Merial, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products and vaccines for pets, production animals, horses, and wildlife | Health Technology |
Montedison Usa, Inc. | |
Rhone-Poulenc Pharmaceuticals, Inc. |
















